Log In
Print
BCIQ
Print
Print this Print this
 

aripiprazole lauroxil (ALKS 9070, ALKS 9072)

  Manage Alerts
Collapse Summary General Information
Company Alkermes plc
DescriptionInjectable, extended-release formulation of aripiprazole using LinkeRx technology
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT) receptor
Mechanism of ActionDopamine D2 receptor agonist; Serotonin (5-HT1A) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today